Claims that a product is "revolutionary," "never
before seen," or providing a solution to an unsolved problem
can be sometimes cavalierly regarded as puffery. We often find
ourselves warning clients that the National Advertising Division
(NAD) has sometimes required advertisers to have a reasonable basis
for innovation claims (i.e., claims that their product is
a breakthrough or somehow entering into a whitespace in a
particular market segment). See Ganeden Biotech, Inc., NAD
Case #4863 (June 2008); Park Labs, NAD Case #4935 (Nov. 2008);
Imagenetix, Inc., NAD Case #5167 (April 2010); The Andrew Jergens
Company, NAD Case #2979 (Oct. 1992); but see Iovate Health
Sciences, Inc. Cold MD, NAD Case #4653 (April 2007); Pilot
Corporation of America, NAD Case #3392 (May 1997); Maximum Human
Performance, LLC, NAD Case #5631 (Sept. 2013). So, it caught our
eye that the United States District Court for the Central District
of California held that these sorts of claims when